Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies

被引：0
作者：
Ana Babic
Xuehong Zhang
Vicente Morales-Oyarvide
Chen Yuan
Natalia Khalaf
Hamed Khalili
Paul Lochhead
Andrew T. Chan
Shuji Ogino
Brian M. Wolpin
Kana Wu
Charles S. Fuchs
Edward L. Giovannucci
Meir J. Stampfer
Kimmie Ng
机构：
[1] Dana-Farber Cancer Institute,Channing Division of Network Medicine, Department of Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Gastroenterology, Hepatology, and Endoscopy
[3] Brigham and Women’s Hospital and Harvard Medical School,Clinical and Translational Epidemiology Unit, Department of Medicine
[4] Massachusetts General Hospital,Division of Gastroenterology
[5] Massachusetts General Hospital and Harvard Medical School,Program in MPE Molecular Pathological Epidemiology, Department of Pathology
[6] Broad Institute of MIT and Harvard,Department of Epidemiology
[7] Brigham and Women’s Hospital and Harvard Medical School,Department of Nutrition
[8] Harvard T.H. Chan School of Public Health,Department of Medicine
[9] Harvard T.H. Chan School of Public Health,undefined
[10] Yale Cancer Center,undefined
[11] Yale School of Medicine,undefined
[12] Smilow Cancer Hospital,undefined
来源：
British Journal of Cancer | 2020年 / 123卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：844 / 851
页数：7
相关论文
共 169 条
[1]  
Schubert ML(2008)Control of gastric acid secretion in health and disease Gastroenterology 134 1842-1860
[2]  
Peura DA(2017)The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal Eur. J. Intern. Med. 37 19-24
[3]  
Savarino V(2017)The safety of appropriate use of over-the-counter proton pump inhibitors: an evidence-based review and Delphi consensus Drugs 77 547-561
[4]  
Dulbecco P(1984)Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels Gastroenterology 87 1030-1034
[5]  
de Bortoli N(1992)Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients Hepato-Gastroenterology 39 366-370
[6]  
Ottonello A(2002)Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level Int. J. Clin. Pharm. Res. 22 29-35
[7]  
Savarino E(1999)Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation J. Clin. Invest. 103 1119-1126
[8]  
Johnson DA(2002)Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence Br. J. Cancer 87 567-573
[9]  
Katz PO(2001)Hypergastrinemia promotes adenoma progression in the APC(Min−/+) mouse model of familial adenomatous polyposis Cancer Res. 61 625-631
[10]  
Armstrong D(1998)Gastrin and colorectal cancer: a prospective study Gastroenterology 115 275-280
12345678910